Clinical Trial: Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163845) titled 'Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil' on Sept. 01.

Brief Summary: This is a cross-sectional serosurvey using household cluster sampling conducted before the VLA1553 pilot vaccination strategy will be implemented in about 10 municipalities in Brazil.

Study Start Date: Sept. 08

Study Type: OBSERVATIONAL

Condition: Chikungunya Virus Infection

Intervention: BIOLOGICAL: Live-attenuated CHIKV vaccine VLA1553

Non-interventional study: VLA1553 is used in the pilot vaccination strategy which is car...